GlassScriptPhysician profile
Michael C Casciello
NPI 1639166960
$11,508.67
in general payments reported to CMS, 2019-2025
57 companies · $1,125 in 2025
The $1,125 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,814 · 2020: $1,330 · 2021: $1,863 · 2022: $1,753 · 2023: $1,870 · 2024: $1,753 · 2025: $1,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,728 · Education: $20.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,728.27 |
| Education | $20.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,040.18 | 2019-2025 | Amplatzer Amulet, Amplatzer Talisman, Mitraclip |
| Novartis Pharmaceuticals Corporation | $1,017.11 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $752.78 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $679.72 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $648.09 | 2019-2025 | Brilinta |
| Medtronic Vascular, INC. | $553.38 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $547.54 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Actelion Pharmaceuticals US, INC. | $521.21 | 2019-2025 | Opsumit, Uptravi |
| Medtronic, INC. | $497.41 | 2021-2025 | Micra, Corevalve Evolut R, Tyrx |
| Amgen INC. | $472.26 | 2019-2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $434.03 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $395.58 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $387.79 | 2019-2024 | |
| United Therapeutics Corporation | $310.50 | 2022-2025 | Tyvaso, Tyvaso, Orenitram |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $301.42 | 2019-2025 | Lifevest |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $241.74 | 2024-2025 | |
| Esperion Therapeutics, INC. | $239.19 | 2020-2023 | Nexletol |
| Pfizer INC. | $223.16 | 2019-2025 | |
| Novo Nordisk INC | $213.06 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $202.34 | 2021-2025 | |
| Cvrx, INC. | $180.52 | 2022-2025 | Barostim Neo System |
| Biotronik INC. | $165.52 | 2019 | |
| Baxter Healthcare | $163.24 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Cardioperfect Pro Ecg Recorder |
| Irhythm Technologies, INC. | $159.12 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Acacia Pharma INC | $127.47 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $112.44 | 2023-2024 | Inpefa |
| Cardiva Medical, INC. | $92.28 | 2021-2023 | Cardiva Vascade 6/7f Vcs |
| Kowa Pharmaceuticals America, INC. | $70.13 | 2020-2021 | |
| Abiomed | $59.71 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $55.19 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $52.82 | 2025 | Amvuttra |
| Daiichi Sankyo INC. | $52.04 | 2021-2023 | Injectafer |
| Edwards Lifesciences Corporation | $45.24 | 2019-2022 | |
| Azurity Pharmaceuticals, INC. | $37.12 | 2025 | Edarbyclor, Edarbi |
| Teleflex LLC | $35.83 | 2022-2023 | Vascband |
| Gilead Sciences, INC. | $35.51 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $35.16 | 2019 | |
| Lundbeck LLC | $27.17 | 2020 | |
| Medicomp INC | $26.74 | 2024 | Telepatch Cardiac Monitor |
| Eagle Pharmaceuticals, INC. | $24.96 | 2024 | |
| Bardy Diagnostics, INC. | $24.89 | 2022 | |
| Vital Connect, INC | $20.47 | 2025 | Vitalpatch Rtm |
| Boston Scientific Corporation | $19.39 | 2019 | |
| Genzyme Corporation | $19.07 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.07 | 2024 | Zilretta, Iovera, Exparel |
| Mannkind Corporation | $17.94 | 2025 | |
| Angiodynamics, INC. | $16.75 | 2023 | Angiovac |
| Glaxosmithkline, LLC. | $14.81 | 2025 | Shingrix, Arexvy |
| G Medical Diagnostic Services, INC. | $14.67 | 2022 | |
| Chiesi USA, INC. | $14.17 | 2019 | |
| Cook Medical LLC | $14.09 | 2021 | |
| Philips North America LLC | $13.99 | 2020 | |
| Lemaitre Vascular, INC. | $13.66 | 2019 | |
| Allergan, INC. | $13.18 | 2019 | |
| Astellas Pharma US INC | $13.04 | 2020 | |
| Elutia, INC. | $12.64 | 2022 | |
| Sun Pharmaceutical Industries INC. | $11.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Casciello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.